SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) - A clinical trial for the novel administration of immunotherapy for bladder cancer

A. Moe, D. Hayne

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)20-21
Number of pages2
JournalBJU International
Volume125
Publication statusPublished - Mar 2020
Event73rd Annual Scientific Meeting of the Urological Society of Australia and New Zealand - Sydney, Australia
Duration: 7 Mar 202010 Mar 2020

Cite this